• Fulfilling

    Potential

    With the Science of Enzymes

  • Fulfilling

    Potential

    In the Treatment of 

    Gastrointestinal and Rare Diseases

  • Helping

    Patients

    Fulfill Their Potential

News & Media

Alcresta Therapeutics’ RELiZORB™ Increases Fat Absorption in Adult and Pediatric Patients with Cystic Fibrosis Receiving Enteral Nutrition

Oct 28, 2016

RELiZORB significantly increased plasma levels of DHA and EPA fatty acids and patients report a decrease in the frequency and severity of gastrointestinal symptoms

RELiZORB™ Recognized for Medical Design Excellence

Jul 26, 2016

Alcresta Therapeutics’ RELiZORB, a first-of-its kind digestive enzyme cartridge designed to mimic the function of pancreatic lipase, was selected as the Gold Winner at the Medical Device Excellence Awards (MDEA).

Alcresta Therapeutics Launches RELiZORB™ in the U.S.

Jun 07, 2016

First Digestive Enzyme Cartridge Designed to Improve Digestion of Essential Fats in Enteral Tube Feeding